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In the general population, older age is associated with short leukocytetelomere length and with high risk of infections. In a recent study ofallogeneic hematopoietic cell transplantation for severe aplastic ane-
mia, long donor leukocyte telomere length was associated with
improved survival in the recipients.  These findings suggest that leuko-
cyte telomere length could possibly be a marker of immune competence.
Therefore, we tested the hypothesis that shorter leukocyte telomere
length is associated with higher risk of infectious disease hospitalization
and infection-related death. Relative peripheral blood leukocyte telomere
length was measured using quantitative polymerase chain reaction in
75,309 individuals from the general population and the individuals were
followed for up to 23 years. During follow up, 9228 individuals were
hospitalized with infections and infection-related death occurred in 1508
individuals. Shorter telomere length was associated with higher risk of
any infection (hazard ratio 1.05 per standard deviation shorter leukocyte
telomere length; 95% confidence interval 1.03-1.07) and pneumonia
(1.07; 1.03-1.10) after adjustment for conventional infectious disease risk
factors. Corresponding hazard ratios for infection-related death were
1.10 (1.04-1.16) for any infection and 1.11 (1.04-1.19) for pneumonia.
Telomere length was not associated with risk of skin infection, urinary
tract infection, sepsis, diarrheal disease, endocarditis, meningitis or other
infections. In conclusion, our findings indicate that leukocyte telomere
length may be a marker of immune competence. Further studies are
needed to determine whether risk of infections in allogeneic hematopoi-
etic cell transplantation recipients can be reduced by considering donor
leukocyte telomere length when selecting donors.
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ABSTRACT
Introduction
Telomeres are located at the chromosome tips and are composed of protein and
tandem repeats of the nucleotide sequence TTAGGG.1 In most cell types, the
telomeric DNA becomes shorter with each mitotic cell division due to the end repli-
cation problem.2,3 If telomeres reach a critically short length, further cell divisions
may not be possible and cells become senescent or undergo apoptosis.1,4
In the general population, older age is associated with short telomere length in
peripheral blood leukocytes and with high risk of infections,5-7 but it is currently
unknown whether short leukocyte telomere length is a cause of impaired immune
competence.8 In a recent study of allogeneic hematopoietic cell transplantation
(allo-HCT) for severe aplastic anemia, long donor leukocyte telomere length was
associated with improved long-term survival in the recipi-
ents.9 Due to insufficient statistical power in the analysis
of cause-specific deaths, the study could not identify the
reason why survival was higher in patients receiving
transplants from donors with long leukocyte telomere
length. Since infections are among the leading causes of
death in aplastic anemia patients treated with allo-
HCT,10,11 a possible explanation could be that leukocyte
telomere length is a marker of overall immune compe-
tence in the donor. However, no previous studies have
examined the association between telomere length and
risk of hospitalization for infectious disease  in the general
population, and studies on telomere length and risk of
infection-related death have produced conflicting results.12-
15 If leukocyte telomere length is a marker of overall
immune competence in the general population, it would
indicate that shortening of telomeres may be one of the
biological mechanisms underlying age-related decline in
adaptive immunity and increase in infectious disease sus-
ceptibility. It is currently unknown whether a marker of
immune competence can be useful for making decisions
on treatment or other health interventions in individuals
from the general population, but such a marker may
potentially be useful when selecting donors for allo-HCT.
Therefore, examination of the possible association
between leukocyte telomere length and immune compe-
tence could provide important information of clinical as
well as biological relevance.
Given this, we studied 75,309 individuals from the gen-
eral population to test the hypothesis that shorter telom-
ere length in leukocytes is associated with higher risk  of
hospitalization for infectious disease  and higher risk of
infection-related death. All individuals had telomere
length measured in peripheral blood leukocytes at study
enrollment and the participants were prospectively fol-
lowed for up to 23 years for hospitalization for infectious
disease and death.
Methods
Participants
We studied 75,309 individuals from two studies of the general
population: 8681 individuals from the Copenhagen City Heart
Study16,17 (enrolled between 1991 and 1994) and 66,628 individuals
from the Copenhagen General Population Study18,19 (enrolled
between 2003 and 2012). Using the Danish Civil Registration
System,20 which includes a unique identification number for all
individuals with permanent residence in Denmark, the partici-
pants were randomly invited to represent the general population
aged 20-100 years. In the Copenhagen City Heart study, 61% of
the invited individuals participated, and in the Copenhagen
General Population Study, 46% participated. At the day of exam-
ination, all participants completed a questionnaire on lifestyle and
health, underwent a physical examination, and had blood samples
drawn. None of the individuals participated in both studies.
Among the participants, more than 99% were white and of
Danish descent. No participants were lost to follow up. The stud-
ies were approved by Danish ethical committees and all partici-
pants provided written, informed consent. 
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Table 1. Baseline characteristics of 75,309 individuals from the general population according to age-adjusted quartiles of leukocyte telomere
length.
Telomere length quartiles
Characteristic 1st (longest) 2nd 3rd 4th (shortest)
Individuals, n. 18,800 18,834 18,816 18,859
Relative telomere length, T/S-ratio 0.79 0.65 0.56 0.45
(0.74-0.88) (0.61-0.68) (0.52-0.59) (0.41-0.50)
Age, years 57 57 57 57
(47-67) (47-67) (47-67) (47-67)
Male sex, n. 7875 8295 8547 9059
(42) (44) (45) (48)
Ever smokers, n. 11,091 11,415 11,646 11,984
(59) (61) (62) (64)
Cumulative smoking#, pack-years 17 18 19 20
(7-31) (7-33) (8-34) (9-35)
Alcohol consumption >168/84 g/week†, n. 7047 7279 7301 7027
(37) (39) (39) (37)
Body mass index, kg/m2 25.4 25.5 25.7 25.8
(23.0-28.2) (23.2-28.5) (23.2-28.5) (23.3-28.8)
Any comorbidity§, n. 3549 3721 3820 3898
(19) (20) (20) (21)
Previously hospitalized‡, n. 8138 8092 8078 8306
(43) (43) (43) (44)
C-reactive protein, mg/L 1.4 1.5 1.5 1.6
(1.0-2.5) (1.1-2.5) (1.1-2.6) (1.1-2.7)
Number (n.) (%) is shown for categorical variables and median (interquartile range, IQR) is shown for continuous variables. #Ever smokers only. †>168 g/week for men and >84
g/week for women. §As defined by the Charlson comorbidity index. ‡Defined as any inpatient hospitalization within ten years before study enrollment for any cause other than
infections.
Covariates
All included covariates were chosen a priori based on previous
studies reporting them to be associated with telomere length and
risk of infections.19,21-24 Information on age and sex was obtained
from the Danish Civil Registration system, while information on
smoking status (current/former/never), cumulative smoking in
pack-years (with one pack-year defined as 20 cigarettes or equiv-
alent per day for a year), alcohol consumption
(none/moderate/heavy, with heavy defined as >168 g/week for
men and >84 g/week for women, as recommended by The
Danish Health Authority), and body mass index (measured
weight in kilograms divided by measured height in meters
squared) was derived from the questionnaire and physical exami-
nation. As a marker of inflammation, plasma high-sensitivity C-
reactive protein level at study enrollment was measured using
standard hospital assays.
Telomere length measurements
After isolation of DNA from peripheral blood leukocytes using
the Qiagen blood kit,25 relative telomere length was measured by
a modified monochrome multiplex quantitative polymerase chain
reaction (qPCR) method,26 as previously described in detail else-
where.19,21 The qPCR method was chosen since this is the only
available method for high-throughput measurements of telomere
length.1,27 In short, the telomere template was amplified simulta-
neously with the single copy gene for albumin in the same well to
adjust for different amounts of DNA in the samples. All samples
were run in quadruplicates. For each sample, we calculated the
ratio between telomere (T) repeat copy numbers and single gene
(S) copy numbers, and the relative telomere length expressed as
the T/S ratio was derived through calibration with measurements
on K562 cell line DNA, which was included in each plate. Using
this method, the T/S ratio of the K562 cell line DNA is by defini-
tion set to 1, so samples with shorter telomere length than K562
cell line DNA have T/S ratios below 1 while samples with longer
telomere length than K562 cell line DNA have T/S ratios above 1.26
To obtain a functional single-calibrator measurement, telomere
length measurements were adjusted across calibrator lots, as
described in detail in the Online Supplementary Methods. The labo-
ratory technician performing all measurements was blinded to
infectious disease endpoints and deaths.
Genotypes
An inherent limitation of observational studies on biomarkers
and risk of disease is their inability to determine whether a bio-
marker are having a causal effect on the risk of disease, or if any
found associations could be due to confounding or reverse causa-
tion. A way of overcoming this limitation is to study whether sin-
gle nucleotide polymorphisms (SNPs) that influence the level of a
biomarker are also associated with risk of disease. Using this
approach, we genotyped participants for the three SNPs,
rs1317082, rs7726159, and rs2487999, to examine whether a
genetic predisposition to shorter telomere length is associated
with risk of infections. The 3 SNPs were chosen based on a
genome wide association study including 26,089 individuals,
which found they were the SNPs most strongly associated with
measured leukocyte telomere length.28 The three genotypes were
combined into an overall unweighted allele score, taking values
from 0 to 6, which was calculated as the sum of the number of
telomere length shortening alleles for each of the three genotypes.
Since there were only 68 individuals with 0 telomere length short-
ening alleles, individuals with an unweighted allele score of 0 and
1 were combined into a single group. Similarly, a weighted allele
score was constructed by first assigning each SNP a weight accord-
ing to the SNPs average per allele effect size on measured T/S
ratio, and then calculating the sum of weighted telomere shorten-
ing alleles for the three SNPs combined. To increase power, geno-
typing was also performed on participants from the two general
population studies for whom measured telomere length was not
available, leading to a total of 107,693 individuals genotyped.
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Figure 1. Risk of first hospitalization for any infection and specific infections in the general population per standard deviation shorter telomere length. The sum of
specific infections exceeds the number of any infection since some individuals had more than one type of infection. Multivariable models were adjusted for values
at study enrollment of age, sex, smoking status, cumulative smoking in pack-years, alcohol consumption, body mass index, plasma C-reactive protein level, Charlson
comorbidity index, number of non-infectious disease hospitalizations within ten years before study enrollment, and study cohort. CI: confidence interval
More details on genotyping are described in the Online
Supplementary Methods. 
Infectious disease endpoints
Using the national Danish Patient Registry,29 which covers all
Danish hospitals, we obtained information for each individual par-
ticipant on inpatient hospitalizations with a primary discharge
diagnosis of an infectious disease from January 1st 1977 until
November 5th 2014. Likewise, we obtained information from the
national Danish Patient Registry on emergency room visits with a
primary diagnosis of an infectious disease from January 1st 1994
until November 5th 2014. Information on vital status and date of
death until November 5th 2014 was retrieved from the Danish
Civil Registration system. For participants who died before
December 31st 2012, information on infection-related deaths was
obtained from the national Danish Register of Causes of Death,30
which covers all deaths in Denmark and registers all diagnoses
that a physician has listed on the death certificate as contributing
to the cause of death. More details on classification of infectious
disease endpoints are described in Online Supplementary Table S1
and in the Online Supplementary Methods. 
Comorbidities
Non-infectious comorbidities could possibly confound the asso-
ciation between telomere length and risk of infections, since short
leukocyte telomere length has been found in individuals with
chronic conditions such as heart failure31 and chronic obstructive
pulmonary disease,32 and individuals with these conditions are
also at high risk of infections.22,24 To reduce such confounding,
comorbidities at study enrollment were assessed using the
Charlson comorbidity index,33 which is a severity weighted meas-
ure of comorbid conditions that has been validated for its ability
to predict mortality.34,35 Individuals at high risk of undiagnosed
comorbidities were identified using measurements of white blood
cell differential count, platelet count, blood hemoglobin, plasma
alanine aminotransferase, plasma creatinine, and non-fasting plas-
ma glucose at study enrollment. These measurements were cho-
sen as a broad screening for hematologic, hepatic, renal, and meta-
bolic diseases. More details on assessment of comorbidities are
described in the Online Supplementary Methods. 
Statistical analysis
Statistical analyses were performed with Stata v. 13.1. All statis-
tical tests were two-sided. Since several studies have documented
a strong association between higher age and shorter telomere
length,5,6,19 calculation of telomere length quartiles was adjusted
for age by computing quartiles of telomere length separately for
each one-year age span. To reduce risk of reverse causation (i.e.
that subclinical infections already present at date of examination
may influence leukocyte telomere length), individuals were only
included in the analyses if they were not hospitalized with any
infection during the first 180 days after the date of examination.
Risk of infectious disease hospitalization and risk of infection-
related death were modeled separately by Cox proportional haz-
ards regression using left-truncated age as the timescale, as
described in detail in the Online Supplementary Methods. For the
analyses on measured telomere length and risk of hospitalization
for infectious disease, and for risk of infection-related death, fol-
low up began 180 days after the date of examination.
Multivariable models were adjusted for values at study enrollment
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Figure 2. Risk of first hospitalization for any infection and pneumonia in the general population according to age-adjusted quartiles of telomere length.
Multivariable models were adjusted for values at study enrollment of age, sex, smoking status, cumulative smoking in pack-years, alcohol consumption, body mass
index, plasma C-reactive protein level, Charlson comorbidity index, number of non-infectious disease hospitalizations within ten years before study enrollment, and
study cohort. CI: confidence interval. 
of age, sex, smoking status, cumulative smoking in pack-years,
alcohol consumption, body mass index, plasma C-reactive protein
level, Charlson comorbidity index, number of non-infectious dis-
ease hospitalizations within ten years before study enrollment,
and study cohort. 
Results
Among 75,309 individuals from the general population,
older age was strongly associated with shorter leukocyte
telomere length with a mean lower  T/S ratio of 0.0032
[95% confidence interval (CI): 0.0032-0.0033; linear
regression P<1*10-300; R-squared=0.073] for each year of
older age. Therefore, baseline characteristics are shown
after adjustment for age by calculation of age-adjusted
quartiles of telomere length (Table 1).
Telomere length and risk of infections
During a median follow up of seven  years (range 0-23
years), 9228 individuals were hospitalized due to infec-
tions. When examining risk of first hospitalization for
infection after study enrollment, a one standard deviation
shorter leukocyte telomere length was associated with
higher risk of any infection [hazard ratio (HR) 1.05;
95%CI: 1.03-1.07] and pneumonia (HR 1.07; 95%CI: 1.03-
1.10) (Figure 1). We found no association between telom-
ere length and risk of skin infection, urinary tract infection,
sepsis, diarrheal disease, endocarditis, meningitis, or other
infections. Similarly, when examining risk of first hospital-
ization for infection according to age-adjusted quartiles of
telomere length, increasing quartiles of telomere length
were associated with higher risk of any infection (P for
trend=1*10-7) and pneumonia (P for trend=3*
10-7) (Figure 2). Hazard ratios for the shortest versus the
longest quartile of telomere length were 1.16 (95%CI:
1.09-1.23) for any infection and 1.25 (95%CI: 1.15-1.36)
for pneumonia.
When including both first and recurrent infectious dis-
ease hospitalizations (Online Supplementary Figure S1), risk
estimates per standard deviation shorter telomere length
were similar to those from the analysis on risk of first hos-
pitalization  for infectious disease (Figure 1).
Stratified analyses on risk of infections
To investigate whether the association between shorter
telomere length and higher risk of any infection and pneu-
monia may be due to reverse causation, we performed
stratified analyses according to follow-up interval. We
found no indication of reverse causation, as risk estimates
for any infection became more pronounced as more time
elapsed after study enrollment (P for interaction with fol-
low-up interval=0.006), while risk estimates for pneumo-
nia were largely stable across follow-up intervals (P for
interaction with follow-up interval=0.09) (Figure 3).
To further examine the robustness of the association
between shorter telomere length and higher risk of any
infection and pneumonia, we performed stratified analy-
ses according to strata of the covariates that were includ-
ed in the multivariable models (Figure 4 and Online
Supplementary Figure S2). To additionally reduce con-
founding by comorbidities that may be undiagnosed at
study enrollment, we also performed stratified analyses
according to whether or not participants had normal
blood laboratory tests at study enrollment. In all of the
above mentioned strata, risk estimates remained stable
for any infection (Figure 4) and pneumonia (Online
Supplementary Figure S2). 
As previous studies have found that shorter telomere
Leukocyte telomere length and risk of infections
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Figure 3. Risk of first hospitalization for any infection and pneumonia in the general population per standard deviation shorter telomere length stratified according
to follow-up interval.  Multivariable models were adjusted for values at study enrollment of age, sex, smoking status, cumulative smoking in pack-years, alcohol con-
sumption, body mass index, plasma C-reactive protein level, Charlson comorbidity index, number of non-infectious disease hospitalizations within ten years before
study enrollment, and study cohort. P for interaction was calculated using a likelihood ratio test, comparing models with and without an interaction term. CI: confi-
dence interval. 
length was associated with higher risk of cardiovascular
disease,21,36-39 and since cardiovascular disease is associated
with high risk of infections,22,24 we investigated whether
the observed association between shorter telomere length
and risk of infections may be secondary to cardiovascular
disease. Risk estimates for any infection and pneumonia
remained stable when the analyses were stratified accord-
ing to whether or not individuals were diagnosed with
any type of cardiovascular disease at study enrollment or
during follow up (Online Supplementary Figure S3).
Similarly, risk estimates for any infection and pneumonia
were stable when including cardiovascular disease diag-
nosed at study enrollment or during follow up as a time-
dependent variable in the multivariable model (Online
Supplementary Figure S4).
Telomere length and risk of infection-related death
One standard deviation shorter telomere length was
associated with higher risk of death related to any infec-
tion (HR 1.10; 95%CI: 1.04-1.16) and pneumonia 
(HR 1.11; 95%CI: 1.04-1.19) (Figure 5). We found no asso-
ciation between shorter telomere length and risk of death
related to sepsis, urinary tract infection, diarrheal disease,
endocarditis, skin infection, or other infections. For
meningitis, exact calculations of risk estimates were not
possible since there were only 2 meningitis-related deaths.
Since previous studies on telomere length and risk of
infection-related death have produced conflicting results
which could potentially be explained by limited statistical
power,12-15 we performed power calculations based on the
risk estimates from our present study and the number of
participants and deaths reported in previous studies
(Online Supplementary Table S2). All four previous studies
each had less than 15% power to detect a hazard ratio for
any infection-related death of 1.10 per standard deviation
shorter telomere length at two-sided P<0.05.
Genetic predisposition to shorter telomere length and
risk of infections
Among the 107,693 genotyped individuals, 21,317 indi-
viduals were hospitalized due to any infection during fol-
low up (see Online Supplementary Table S3 for baseline char-
acteristics). Mean T/S ratio decreased by 0.012 (95%CI:
0.011-0.014) per telomere length shortening allele among
the 75,018 individuals who had both leukocyte telomere
length measurements and genotyping performed (linear
regression on telomere length as a function of unweighted
allele score: standardized β=-0.076; P=2*10-97; R-
squared=0.0058; same regression for weighted allele score:
standardized β=-0.077; P=6*10-99; R-squared=0.0059). For
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Figure 4. Stratified analyses for risk of first hospitalization for any infection per standard deviation shorter telomere length. Number of individuals at risk and num-
ber of infections vary slightly among the stratifications due to varying numbers of individuals with missing data on each of the covariates. Multivariable models were
adjusted for values at study enrollment of age, sex, smoking status, cumulative smoking in pack-years, alcohol consumption, body mass index, plasma C-reactive
protein level, Charlson comorbidity index, number of non-infectious disease hospitalizations within ten years before study enrollment, and study cohort. P for inter-
action was calculated using a likelihood ratio test, comparing models with and without an interaction term. CI: confidence interval. #Ever smokers only. †>168 g/week
for men and >84 g/week for women. §As defined by the Charlson comorbidity index. ‡Defined as any inpatient hospitalization within ten years before study enrollment
for any cause other than infections. ¶Includes measurements of white blood cell differential count, platelet count, blood hemoglobin, plasma alanine aminotrans-
ferase, plasma creatinine, and non-fasting plasma glucose. 
both the unweighted and the weighted allele score, we
found no association between a genetic predisposition to
shorter telomere length and risk of hospitalization for any
infection, pneumonia, skin infection, urinary tract infection,
diarrheal disease, sepsis, meningitis, endocarditis or other
infections (Online Supplementary Figures S5-S7). Importantly,
however, genetic risk estimates did not differ from observa-
tional estimates, but as seen from the power calculation in
the Online Supplementary Results, the rather modest influ-
ence of the SNPs on telomere length leads to very limited
power in the analyses on a genetic predisposition to shorter
telomeres and risk of infections, despite the large number of
individuals genotyped.
Discussion
In this prospective study of 75,309 individuals from the
general population, we found that shorter leukocyte telom-
ere length was associated with higher risk of hospitalization
due to any infection and pneumonia. Likewise, shorter
leukocyte telomere length was associated with higher risk
of death related to any infection and pneumonia. Our find-
ings on telomere length and risk of hospitalization for infec-
tious disease  are novel, while our findings on risk of infec-
tion-related death corroborate the previous studies on this
subject, which had produced conflicting results.12-15 The
higher risk of infections in individuals with shorter leuko-
cyte telomere length could possibly be caused by impaired
adaptive immune function as a consequence of short lym-
phocyte telomere length. This possible mechanism is sup-
ported by a study on the immune response after influenza
vaccination,40 which found that individuals with long
telomere length in B-lymphocytes produced a more robust
antibody response when compared to individuals with
short B-lymphocyte telomere length. Likewise, when pre-
sented with a synthetic influenza peptide in vitro, influenza-
specific CD8+ T-lymphocytes with long telomere length
showed higher proliferative capacity than those with short
telomere length.40 This indicates that telomere length in
subtypes of lymphocytes may be directly related to the
effectiveness of the adaptive immune response.
Furthermore, aging leads to increasing numbers of CD8+ T-
lymphocytes undergoing replicative senescence, and these
senescent lymphocytes are characterized by short telomere
length and no expression of the co-stimulatory molecule
CD28 which is necessary for proliferation.41-44 Combined
with our results, these findings suggest that shortening of
telomeres is likely to be one of the mechanisms underlying
age-related decline in adaptive immunity and increased sus-
ceptibility to infectious disease.7,8 
Our finding that shorter leukocyte telomere length was
associated with higher risk of hospitalization due to any
infection and pneumonia is novel, as no previous studies
have examined the association between leukocyte telomere
length and risk of hospitalization for infectious disease in
the general population. Nonetheless, our results are sup-
ported by a study on 152 individuals,45 which found that
shorter telomere length in peripheral blood mononuclear
cells was associated with higher risk of rhinovirus infection
in healthy volunteers who were quarantined and experi-
mentally exposed to nasal drops containing rhinovirus.
When we investigated risk of specific types of infection,
shorter telomere length was associated exclusively with
higher risk of pneumonia. However, hazard ratios per stan-
dard deviation shorter telomere length was consistently
above 1 for skin infection, diarrheal disease, endocarditis
and meningitis, although these findings were not statistical-
ly significant at a level of  P<0.05. Hypothetically, our find-
ing that pneumonia was the only specific type of infection
with higher risk in individuals with shorter telomeres could
Leukocyte telomere length and risk of infections
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Figure 5. Risk of death related to any infection and death related to specific infections in the general population per standard deviation shorter telomere length.
The sum of deaths related to specific infections exceeds the number of deaths related to any infection since some individuals had more than one type of infection
listed on the death certificate. For meningitis, exact calculations of risk estimates were not possible since there were only 2 meningitis-related deaths. Multivariable
models were adjusted for values at study enrollment of age, sex, smoking status, cumulative smoking in pack-years, alcohol consumption, body mass index, plasma
C-reactive protein level, Charlson comorbidity index, number of non-infectious disease hospitalizations within ten years before study enrollment, and study cohort.
CI: confidence interval. 
simply be due to the high number of hospitalizations for
pneumonia  in the general population, leading to more sta-
tistical power in the analysis on risk of pneumonia than for
other infections. Somewhat similar to our findings, individ-
uals with humoral immunodeficiencies such as X-linked
agammaglobulinemia, common variable immunodeficien-
cy,  and selective immunoglobulin A deficiency have espe-
cially pronounced risk of bacterial respiratory tract infec-
tions, often caused by encapsulated bacteria such as
Streptococcus pneumoniae and Haemophilus influenzae.46 We did
not have information on specific causative pathogens for
hospitalizations for  pneumonia  in the present study, but
other studies have found Streptococcus pneumoniae and
Haemophilus influenzae to be among the most common caus-
es of bacterial pneumonia in the general population.47,48
Hence, the pattern of  risk of infectious disease associated
with shorter telomere length may to some degree resemble
what has been reported for specific deficiencies of the
humoral immune response.
Our finding that shorter leukocyte telomere length was
associated with higher risk of death related to any infection
is supported by two independent prospective cohort stud-
ies, which together  included a total of 1260 individuals, of
whom 83 died from infectious diseases.12,13 However, two
other prospective cohort studies including a total of 3319
individuals and 90 infectious disease deaths found no asso-
ciation between telomere length and risk of death due to
infectious disease.14,15 When calculating power based on the
risk estimates from our present study and the number of
participants and deaths reported in previous studies, the
four previous studies each had less than 15% power to
detect the risk estimate for any infection-related death
found in the present study. This suggests that the conflict-
ing results from previous studies could possibly be related
to limited statistical power because of  the modest number
of  deaths from infectious disease in the study populations,
which is less of a concern in our present study with 75,309
individuals and 1508 infection-related deaths. Importantly,
the precision of the telomere length measurements also
affects power, which is especially relevant since studies on
telomere length and infection-related death have used dif-
ferent methods for measuring telomere length, and since
the precision of the measurements may differ substantially
between methods.49,50
The results from our study and those from previous stud-
ies suggest that leukocyte telomere length may be a marker
of overall immune competence in the general population. It
is still not known whether such a marker can be useful for
making decisions on treatment or other health interven-
tions in individuals from the general population. However,
a marker of overall immune competence could potentially
be useful when selecting donors for allogeneic hematopoi-
etic cell transplantation (allo-HCT), where infections are
among the leading causes of death in the recipients.10,11
Theoretically, it may be possible to reduce the risk of seri-
ous infections and infection-related death in allo-HCT
recipients by including donor telomere length in the selec-
tion criteria when selecting donors. Obviously, this hypoth-
esis cannot be tested in a study of the general population, so
further studies on donor telomere length and the risk of
serious infections and infection-related death in allo-HCT
recipients are needed.
Among the strengths of the current study is the prospec-
tive general population design, the large number of individ-
uals studied, and the availability of detailed information on
possible confounders such as smoking, alcohol intake, body
mass index, hospital diagnosed comorbidities, and meas-
urements of C-reactive protein as a marker of inflamma-
tion. Furthermore, as we have performed measurements of
white blood cell differential count, platelet count, blood
hemoglobin, plasma alanine aminotransferase, plasma cre-
atinine, and non-fasting plasma glucose in a large subgroup
of 66,818 individuals, we were also able to minimize con-
founding by undiagnosed comorbidities by stratifying the
analyses on whether individuals had normal or abnormal
values of these biomarkers.  Due to the observational
nature of the study, we are unable to determine with any
certainty whether the association between leukocyte
telomere length and risk of infections are due to a causal
effect. In an attempt to investigate the question of causality,
we examined the association between a genetic disposition
to shorter telomere length and risk of infections in 107,693
individuals genotyped for the three SNPs that were report-
ed to be most strongly associated with leukocyte telomere
length in a genome wide association study of 26,089 indi-
viduals.28 We found no association between a genetic pre-
disposition to shorter telomere length and risk of any infec-
tion or any type of specific infections, which in principle
indicates that the observational association between shorter
telomere length and higher risk of infections is not due to a
causal effect. However, these results should be interpreted
with caution, as the rather modest influence of the SNPs on
telomere length leads to low statistical power despite the
large number of individuals genotyped, and this limits our
ability to confirm or disprove any hypotheses of causality.
Another limitation of our study is that we only have infor-
mation on hospitalizations for infectious disease while
information on cases of less serious infections that are typ-
ically treated by general practitioners is lacking. In theory,
our findings could be biased if individuals with short telom-
ere length appear frailer than other individuals, which could
lead general practitioners to have  a lower threshold for
admitting these patients for hospital treatment. However, it
is unlikely that our findings are caused solely by such a dif-
ferential referral bias, as shorter telomere length was also
associated with higher risk of death related to any infection
and pneumonia.
In conclusion, we prospectively followed 75,309 individ-
uals from the general population for up to 23 years and
found that shorter leukocyte telomere length was associat-
ed with higher risk of any infection and pneumonia. These
findings indicate that leukocyte telomere length may be a
marker of immune competence among individuals from the
general population. Further studies are needed to determine
whether risk of infections in allo-HCT recipients can be
reduced by considering donor leukocyte telomere length
when selecting donors.
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